Th17 cells expressing KIR3DL2+are increased in ankylosing spondylitis

Th17 cells expressing KIR3DL2+are increased in ankylosing spondylitis

Bibliographic Details
Main Authors:	Ridley, A, Kollnberger, S, Shaw, J, Wong, I, Chan, A, Cummings, F, Fleming, M, Bowness, P
Format:	Conference item
Published:	2010

Similar Items

Th17 cells expressing KIR3DL2 and enriched for gut homing markers are increased in ankylosing spondylitis
by: Ridley, A, et al.
Published: (2011)

TH17 CELLS EXPRESSING KIR3DL2 AND ENRICHED FOR GUT HOMING MARKERS ARE INCREASED IN ANKYLOSING SPONDYLITIS
by: Ridley, A, et al.
Published: (2012)

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
by: Bowness, P, et al.
Published: (2011)

TH17 CELLS EXPRESSING KIR3DL2 AND ENRICHED FOR GUT HOMING MARKERS ARE INCREASED IN ANKYLOSING SPONDYLITIS
by: Ridley, A, et al.
Published: (2012)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
by: Kollnberger, S, et al.
Published: (2010)

KIR3DL2 INTERACTION WITH HLA-B27 PROMOTES THE SURVIVAL OF TH17 CELLS IN ANKYLOSING SPONDYLITIS
by: Kollnberger, S, et al.
Published: (2010)

Increased IL-23 receptor expression is observed on KIR3DL2+CD4+T cells in Ankylosing Spondylitis and correlates with IL-23R polymorphisms
by: Ridley, A, et al.
Published: (2013)

Increased IL-23 Receptor Expression Is Observed On KIR3DL2+CD4+T Cells In Ankylosing Spondylitis and Correlates With IL-23R Polymorphisms
by: Ridley, A, et al.
Published: (2013)

CHARACTERIZING TYPE 17 IMMUNE RESPONSES IN ANKYLOSING SPONDYLITIS
by: Al-Mossawi, H, et al.
Published: (2013)

TH17 T CELLS IN ANKYLOSING SPONDYLITIS ARE POLYFUNCTIONAL AND EXPRESS HIGH LEVELS OF THE CHEMOKINE RECEPTOR CCR6
by: Bowness, P, et al.
Published: (2009)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.
by: McCappin, J, et al.
Published: (2010)

Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
by: Chen, L, et al.
Published: (2015)

KIR3DL2 Binds to HLA-B27 Dimers and Free H Chains More Strongly than Other HLA Class I and Promotes the Expansion of T Cells in Ankylosing Spondylitis.
by: Wong-Baeza, I, et al.
Published: (2013)

KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.
by: Wong-Baeza, I, et al.
Published: (2013)

Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
by: Hammitzsch, A, et al.
Published: (2018)

Lack of association of KIR3DL1 or KIR3DS1 with ankylosing spondylitis in a UK population
by: Harvey, D, et al.
Published: (2007)

THE ROLE OF HLA-B27 KIR3DL2 INTERACTIONS IN THE PATHOGENESIS OF SPONDYLOARTHRITIS
by: Kollnberger, S, et al.
Published: (2012)

No association of alleles of the killer immunoglobulin-like receptor gene KIR3DL2 with ankylosing spondylitis
by: Harvey, D, et al.
Published: (2008)

Expansion and increased survival of natural killer and CD4 T cells expressing the Killer IG-like Receptor KIR3DL2 in spondyloarthritis.
by: Chan, A, et al.
Published: (2005)

miR-10b-5p is a novel Th17 regulator present in Th17 cells from Ankylosing Spondylitis
by: Chen, L, et al.
Published: (2017)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis (vol 75, pg 68, 2009)
by: McCappin, J, et al.
Published: (2011)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
by: Bowness, P, et al.
Published: (2010)

TARGETING MONOCYTE-EXPRESSED HLA-B27 HOMODIMERS IN ANKYLOSING SPONDYLITIS
by: Bowness, P, et al.
Published: (2010)

The immunology of Ankylosing Spondylitis
by: Bowness, P
Published: (2011)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
by: Ridley, A, et al.
Published: (2013)

HLA-B*2709, A SUBTYPE NOT ASSOCIATED WITH ANKYLOSING SPONDYLITIS, FORMS FEWER HOMODIMERS THAN HLA-B*2705
by: Giles, J, et al.
Published: (2010)

Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis.
by: Chan, A, et al.
Published: (2005)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
by: Wong-Baeza, I, et al.
Published: (2011)

Enhanced Expression of KIR3DL2 in Natural Killer and CD3/CD4 Positive T Cells of Ankylosing Spondylitis Patients Compared to HLA-B*2705 or B*2709 Healthy Subjects
by: Cauli, A, et al.
Published: (2011)

OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
by: Bowness, P
Published: (2012)

EXPRESSION OF HLA-B27 HEAVY CHAIN FORMS IN ANKYLOSING SPONDYLITIS AND HLA-B27 POSITIVE CELL LINES
by: Rysnik, O, et al.
Published: (2012)

INVESTIGATING THE ROLE OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE-1 IN ANKYLOSING SPONDYLITIS
by: Chen, L, et al.
Published: (2012)

HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers
by: Giles, J, et al.
Published: (2010)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
by: Kollnberger, S, et al.
Published: (2007)

EPIGENETIC REGULATION OF THE IL-23R LOCUS IN ANKYLOSING SPONDYLITIS
by: Cohen, C, et al.
Published: (2013)

GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
by: Shi, H, et al.
Published: (2020)

New developments in our understanding of Ankylosing Spondylitis pathogenesis
by: Voruganti, A, et al.
Published: (2020)

Progress in our understanding of the pathogenesis of ankylosing spondylitis
by: Simone, D, et al.
Published: (2018)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.
by: Shaw, J, et al.
Published: (2012)

Molecular determinants for KIR3DL2 binding to HLA-B27 and other HLA-class I ligands
by: Hatano, H, et al.
Published: (2013)